Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.210
-0.110 (-2.55%)
At close: May 18, 2026, 4:00 PM EDT
4.200
-0.010 (-0.24%)
Pre-market: May 19, 2026, 7:20 AM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.47 billion as of May 19, 2026. Its market cap has increased by 90.12% in one year.
Market Cap
1.47B
Enterprise Value
1.15B
1-Year Change
90.12%
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.47B, an increase of 740.18%. That is a compound annual growth rate of 45.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.50B | -51.03% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.51B |
| Palvella Therapeutics | 1.51B |
| Damora Therapeutics | 1.50B |
| GH Research | 1.49B |
| Vir Biotechnology | 1.48B |
| MBX Biosciences | 1.47B |
| Novavax | 1.47B |
| Precigen | 1.45B |